期刊文献+

肝硬化患者血清脂联素水平与胰岛素抵抗相关性 被引量:2

下载PDF
导出
摘要 目的探讨肝硬化患者血清脂联素与空腹胰岛素(Fins)、空腹血糖(FPG)以及胰岛素敏感指数(ISI)的相关性。方法选取40例乙型肝炎后肝硬化患者作为观察组,20例正常体检者为对照组,比较两组血清脂联素、胰岛素、血糖和ISI。并根据ChildPugh改良分级法,分析观察组中A、B、C三个级别患者血清脂联素与Fins,FPG及ISI的相关性。结果肝硬化患者FPG及Fins水平均高于对照组,而血清脂联素、ISI则低于对照组,差异均有统计学意义(P<0.01)。不同分级肝硬化患者血清脂联素、FPG、Fins及ISI水平组间差异均有统计学意义(P<0.01)。进一步两两比较发现,各组间血清脂联素、FPG、Fins及ISI水平差异均有显著性(P<0.05),均数大小顺序血清脂联素与ISI水平是A>B>C,在FPG与Fins是C>B>A。肝硬化患者血清脂联素水平与FPG、Fins呈负相关,与ISI呈正相关(P均<0.05)。结论肝硬化患者中存在与胰岛素抵抗密切相关的脂联素代谢紊乱。
作者 吴汉维
出处 《右江医学》 2008年第2期143-144,共2页 Chinese Youjiang Medical Journal
  • 相关文献

参考文献9

  • 1赵春梅,陈福琴.脂联素与2型糖尿病的研究进展[J].中国老年学杂志,2006,26(11):1595-1597. 被引量:5
  • 2Pankowska E, Szalecki M. Adiponectin as an adipose tissue hormone and its role in the metabolic syndrome and cardiovascular disease[J]. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw, 2005,11 (3) : 187-- 190.
  • 3Shimomura I, Maeda K, Nakamura T, et al. Metabolic syndrome and adiponectin[J]. Masui, 2006,55 ( Suppl):S11 -- 17.
  • 4Marra F, Aleffi S, Bertolani C,et al. Adipokines and liver fibrosis[J]. Eur Rev Med Pharmacol Sci,2005,9(5) :279-- 284.
  • 5Despres JP. Cardiovascular disease under the influence of excess visceral fat[J ]. Crit Pathw Cardiol, 2007,6 (2) : 51 -- 59.
  • 6Vasseur F, Meyre D, Froguel P. Adiponeetin, type 2 diabetes and the metabolic syndrome:lessons from human genetic studies[J]. Expert Rev Mol Med,2006,8(27) : 1-- 12.
  • 7Gustafson B, Hammarstedt A, Andersson CX,et al. Inflamed adipose tissue:a culprit underlying the metabolic syndrome and atherosclerosis[J]. Arterioscler Thromb Vasc Biol, 2007, 27 ( 11 ) : 2276--2283.
  • 8Klebanova EM, Balabolkin MI, Kreminskaia VM. The role of the fat tissue and its hormones in the mechanisms of insulin resistance and the development of type 2 diabetes mellitus[J]. Klin Med (Mosk) ,2007,85(7) :20--27.
  • 9Marra F, Aleffi S, Bertolani C,et al. Adipokines and liver fibrosis[J]. Eur Rev Med Pharmacol Sci,2005,9(5) :279--284.

二级参考文献37

  • 1Scherer PE,Willims S,Fogliano M,et al.A novel serum protein similar to C1q,produced exclusively in adipocytes[J].J Biol Chem,1995; 270:26746-9.
  • 2Arita Y,Kihara S,Ouchi N,et al.Paradoxical decrease of an adipose-specific protein,adiponectin,in obesity[J].Biochem Biophys Res Commu,1999 ;257:79-83.
  • 3Kopp HP,Krzyzanowska K,Mohlig M,et al.Effects of marked weight loss on plasma levels of adiponectin,markers of chronic subclinical inflammation and insulin resistance in morbidly obese women[J].Int J Obes (Lond),2005 ;29(7):766-71.
  • 4Fu Y,Luo N,Klein RL,et al.Adiponectin promotes adipocyte differentiation,insulin sensitivity,and lipid accumulation[J].J Lipid Res.2005 ;46(7):1369-79.
  • 5Yamamoto Y,Hirose H,Saito I,et al.Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol,independent of body mass index,in the Japanese population[J].Clin Sci,2002;103(2):137-42.
  • 6Lindsay RS,Funahashi T,Hanson RL,et al.Adiponectin and development of type 2 diabetes in the Pima Indian population[J].Lancet,2002;360:57-8.
  • 7Yokoyama H,Emoto M,Mori K,et al.Plasma adiponectin level is associated with insulin-stimulated non-oxidative glucose disposal[J].J Clin Endocrinol Metab,2006 ;91 (1):290-4.
  • 8Retnakaran R,Hanley A J,Raif N,et al.Adiponectin and beta cell dysfunction in gestational diabetes:pathophysiological implications[J].Diabetologia,2005 ;48 (5):993-1001.
  • 9Yamauchi T,Kamon J,Ito Y,et al.Cloning of adiponectin receptors that mediate antidiabetic metabolic effects[J].Nature,2003; 423:762-9.
  • 10Fasshauer M,Klein J,Kralisch S,et al.Growth hormone is a positive regulator of adiponectin receptor 2 in 3T3-L1 adipocytes[J].FEBS Lett,2004 ;558:27-32.

共引文献4

同被引文献9

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部